Search Results - PHARMACOLOGY OF DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM

Refine Results
  1. 1

    Pharmacokinetic and pharmacodynamic herb-drug interactions—part I. Herbal medicines of the central nervous system by Szilvia Czigle, Milan Nagy, Přemysl Mladěnka, Jaroslav Tóth, the OEMONOM.

    Published in PeerJ (2023-11-01)
    Get full text
    Article


  2. 2

    Glia from the central and peripheral nervous system are differentially affected by paclitaxel chemotherapy via modulating their neuroinflammatory and neuroregenerative properties by Ines Klein, Janne Boenert, Felix Lange, Britt Christensen, Meike K. Wassermann, Martin H. J. Wiesen, Daniel Navin Olschewski, Monika Rabenstein, Carsten Müller, Helmar C. Lehmann, Gereon Rudolf Fink, Gereon Rudolf Fink, Michael Schroeter, Michael Schroeter, Maria Adele Rueger, Maria Adele Rueger, Sabine Ulrike Vay

    Published in Frontiers in Pharmacology (2022-11-01)
    Get full text
    Article


  3. 3

    A Review on Lactoferrin and Central Nervous System Diseases by Yu-Qi Li, Chuang Guo

    Published in Cells (2021-07-01)
    “…Central nervous system (CNS) diseases are currently one of the major health issues around the world. …”
    Get full text
    Article


  4. 4

    Gastrointestinal System Adverse Drug Reactions in Geriatric Patients in Odisha by Satyabrata Sahoo, Suhasini Dehury, Dhirendra Nath Maharana, Shambo Samrat Samajdar

    Published in Bengal Physician Journal (2023-01-01)
    Get full text
    Article


  5. 5

    Nanotechnology-based drug delivery for the treatment of CNS disorders by Mittal Khushi R., Pharasi Nandini, Sarna Bhavya, Singh Manisha, Rachana, Haider Shazia, Singh Sachin Kumar, Dua Kamal, Jha Saurabh Kumar, Dey Abhijit, Ojha Shreesh, Mani Shalini, Jha Niraj Kumar

    Published in Translational Neuroscience (2022-12-01)
    Get full text
    Article


  6. 6

    An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life by Stefano Stagi, Giovanna Municchi, Marta Ferrari, Malgorzata Gabriela Wasniewska

    Published in Frontiers in Endocrinology (2022-06-01)
    Get full text
    Article


  7. 7

    Examination of central nervous system by functional observation battery after massive intravenous infusion of carbon monoxide-bound and oxygen-bound hemoglobin vesicles in rats by Hiromi Sakai, Shunichi Yasuda, Chie Okuda, Tetsuya Yamada, Keita Owaki, Yoji Miwa

    Get full text
    Article


  8. 8

    Gene Therapy Tools for Brain Diseases by Selene Ingusci, Gianluca Verlengia, Gianluca Verlengia, Marie Soukupova, Silvia Zucchini, Silvia Zucchini, Michele Simonato, Michele Simonato

    Published in Frontiers in Pharmacology (2019-07-01)
    Get full text
    Article


  9. 9

    Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy by Amber Hassan, Raffaella di Vito, Tommaso Nuzzo, Matteo Vidali, Maria Jose Carlini, Shubhi Yadav, Hua Yang, Adele D'Amico, Xhesika Kolici, Valeria Valsecchi, Chiara Panicucci, Giuseppe Pignataro, Claudio Bruno, Enrico Bertini, Francesco Errico, Livio Pellizzoni, Alessandro Usiello

    Published in Neurobiology of Disease (2025-04-01)
    Get full text
    Article


  10. 10

    Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways by Jingjie Huang, Bangqi Wu, Peng Qin, Yupei Cheng, Ziyi Zhang, Yameng Chen

    Published in Frontiers in Cardiovascular Medicine (2023-11-01)
    “…With the increasing refinement of the overall mechanisms of KAF and AFDAS, a deeper exploration of physiological pathology, and comprehensive research on the brain-heart relationship, it is imperative to shift from long-term symptom management to more precise and optimized treatment methods that are effective for almost all patients. We anticipate that drugs or non-drug therapies targeting the central nervous system and upstream pathways can guide the simultaneous treatment of multiple downstream pathways in AF, thereby becoming a new breakthrough in AF treatment research.…”
    Get full text
    Article


  11. 11

    3D in vitro blood–brain barrier models: recent advances and their role in brain disease research and therapy by Laura O’Halloran, Olutoyosi Akinsete, A. Leah Kogan, Michelle Wrona, Amira F. Mahdi, Amira F. Mahdi, Amira F. Mahdi

    Published in Frontiers in Pharmacology (2025-10-01)
    Get full text
    Article


  12. 12

    Molecular Aspects of Geriatric Pharmacotherapy by Patryk Rzeczycki, Oliwia Pęciak, Martyna Plust, Marek Droździk

    Published in Cells (2025-09-01)
    Get full text
    Article


  13. 13

    TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons by Wendy Wing Sze Yue, Lin Yuan, Joao M Braz, Allan I Basbaum, David Julius

    Published in eLife (2022-08-01)
    “…Thus, TRPV1 drugs alter core body temperature by modulating sensory input to the central nervous system, rather than through peripheral actions on the vasculature. …”
    Get full text
    Article


  14. 14

    Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease by Andrea Perrelli, Annalisa Bozza, Chiara Ferraris, Sara Osella, Andrea Moglia, Silvia Mioletti, Luigi Battaglia, Saverio Francesco Retta

    Published in Biomedicines (2023-02-01)
    “…Cerebral cavernous malformation (CCM) or cavernoma is a major vascular disease of genetic origin, whose main phenotypes occur in the central nervous system, and is currently devoid of pharmacological therapeutic strategies. …”
    Get full text
    Article


  15. 15

    Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system by Ashwin Kamath

    Published in Scientific Reports (2025-01-01)
    Get full text
    Article


  16. 16

    Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems by Alosh Greeny, Ayushi Nair, Prashant Sadanandan, Sairaj Satarker, Ademola C. Famurewa, Madhavan Nampoothiri

    Published in Biology (2024-02-01)
    Get full text
    Article


  17. 17

    Modern strategy and prospects in pharmacological treatment of Parkinson's disease by А. V. Kutsak, N. M. Buchakchyiska

    Published in Zaporožskij Medicinskij Žurnal (2017-02-01)
    “…PD is a chronic, neurodegenerative steadily progressive disease of the central nervous system, primarily associated with the degeneration of dopamine-producing neurons in the cerebral pulp, manifested by motor and non-motor disorders and leading to permanent disability. …”
    Get full text
    Article


  18. 18

    Pharmacological properties and therapeutic potential of berberine: a comprehensive review by Ke-Qin Fan, Ke-Qin Fan, Liangming Zhang, Fangyu Song, Fangyu Song, Yue-Hui Zhang, Tong Chen, Xiang Cheng, Ning Su, Yan Zou, Ting Yu, Futing Tan, Wenhao Xu, Zijun Yan, Zijun Yan

    Published in Frontiers in Pharmacology (2025-08-01)
    Get full text
    Article


  19. 19

    Hyperlipidemia Increases Nalbuphine Brain Accumulation with Multiple Dosing without Affecting Its Analgesic Response—Its Respiratory Depression Potential Should Be Investigated in... by Marwa E. Elsherbiny, May Almukainzi, Eman Amer, Marwan Emara

    Published in Pharmaceuticals (2024-02-01)
    Get full text
    Article


  20. 20

    Interaction of drugs and coffee by Anton P. Pereverzev, Olga D. Ostroumova

    Published in Consilium Medicum (2021-10-01)
    “…For example, the instructions for the medical use of drugs adrenergic receptor antagonists (for example, salbutamol, salmeterol, epinephrine) and methylxanthines (aminophylline, theophylline) contain information that the joint intake of coffee contributes to additional stimulation of the central nervous system and increases their toxicity. …”
    Get full text
    Article


Search Tools: